2023:
Verkkoniemi-Ahola A., Hartikainen P., Hassi K., Kuusisto H., Lahdenperä S., Mehtälä J., Viitala M., Ylisaukko-oja T., Soilu-Hänninen M. Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients, MSJ-ETC, 2023 (In press)
Loponen H., Mehtälä J., Ylisaukko-oja T., Brück O., Porkka K., Koskenvesa P., Saukkonen K., Lievonen J. Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in Finland, eJHaem 2023 (in press)
Kankaanranta H., Viinanen A., Ilmarinen P., Hisinger-Mölkänen H., Mehtälä J., Ylisaukko-oja T., Idänpään-Heikkilä J.J., Lehtimäki L. Comorbidity burden in severe and non-severe asthma: a nationwide observational study (FINASTHMA), JACI in Practice, 2023 (In press)
Ersbøll A.K., Kristensen M.S., Nybo M, Hede S.M., Mikkelsen K.H., Gislason G., Larsen M.L., Green A. Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study. PLoS One. 2023; 18(5):e0286376.
Ankarfeldt M.Z., Petersen J., Andersen J. A., Fernandes M.F.S., Li H., Motsko S.P., Fast T. & Jimenez-Solem E. Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study, Drugs Real World Outcomes. 2023; 10(1):69-81.
Article
PubMed
Mehtälä J., Ali M., Miettinen T., Partanen L., Laapas K., Niemelä P.T., Khorlo I., Strom S., Kurki S., Vapalahti S., Abdelgawwad K., Leinonen J.V., Utilization of anonymization techniques to create an external control arm for clinical trial data. 2023. Research Square. https://doi.org/10.21203/rs.3.rs-2727105/v1 (Preprint)
Vesikansa A., Mehtälä J., Pesu M., Aaltonen J., Konttinen R., Tasanen K., Huilaja L. Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study. 2023. Acta Derm Venereol. 2023, 103:adv00886. doi: 10.2340/actadv.v103.3491.
Vesikansa A., Mehtälä J., Mutanen K., Lundqvist A., Laatikainen T., Ylisaukko-oja T., Saukkonen T., Pietiläinen K. H., The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland, J Mark Access Health Policy. 2023, 11(1):2166313. doi: 10.1080/20016689.2023.2166313.
2022:
Vesikansa A., Halminen O., Mehtälä J., Hörhammer I., Mikkola T., Ylisaukko-oja T., Linna M. Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: A Finnish nationwide register study, Eur J Health Econ. 2022. doi: 10.1007/s10198-022-01553-8.
Loponen H., Barker H., Ylisaukko-oja T., Bärlund M., Tanner M. Rintasyövän neoadjuvanttihoidon toteutuminen ja tulokset. Suom Lääkäril 2022; 77 : e33517 (Published 23.9.2022)
Vesikansa A., Mehtälä J., Mutanen K., Lundqvist A., Laatikainen T., Ylisaukko-oja T., Saukkonen T., Pietiläinen K.H. Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study. Eur J Health Econ 2022; doi: 10.1007/s10198-022-01507-0 (Epub 2022 Sep)
Koistinen V, Kauppi P, Idänpään-Heikkilä J, Veijalainen L, Iso-Mustajärvi I, Ylisaukko-oja T, Mehtälä J, Viinanen A, Kilpeläinen M. Effectiveness of mepolizumab in patients with severe eosinophilic asthma: results from real-world clinical practice in Finland. J Asthma 2022; 1–11.
Vesikansa A, Mehtälä J, Jokelainen J, Mutanen K, Lundqvist A, Laatikainen T, Ylisaukko-oja T, Saukkonen T, Pietiläinen KH. The association of body mass index with quality of life and working ability: a Finnish population-based study. Qual Life Res. 2022; 31(2):413–423. (Epub 2021 Sep)
Ylisaukko-Oja T, Puttonen M, Jokelainen J, Koivusalo M, Tamminen K, Torvinen S, Voutilainen M. Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scand J Gastroenterol 2022; 57(4):415–423. (Epub 2021 Dec).
2021:
Ranti J, Perkonoja K, Kauko T, Loponen H, Joensuu EI, Järvinen TM. Characterization of real-world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center. eJHaem. 2021; 3(1):291–300. (Epub 2021 Nov).
Loponen H, Paajanen J, Vihervaara V, Ylä-Viteli S, Tamminen K, Torvinen S, Jokelainen J, Ylisaukko-oja T, Silvoniemi M. Treatment Patterns and Outcomes in a Cohort of Finnish NSCLC Patients with ALK Rearrangement Reflect Rapid Evolution in Treatment Practices. Int J Clin Exp Med Sci 2021; 7(6):200–209
Metsärinne K, Pietilä M, Katola I, Stenman LK, Hätinen OP, Vesikansa A, Poussa T, Niskanen L. The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF). Prim Care Diabetes 2021; S1751–9918(21)00228-X.
Sandberg A, Ehlers P, Torvinen S, Sandberg H, Sivén M. Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland. Healthcare 2021 (Nov 11); 9(11):1540.
Ankarfeldt MZ, Petersen J, Andersen JT, Li H, Motsko SP, Fast T, Hede SM, Jimenez-Solem E. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden. PLoS Med 2021;18(11):e1003851.
Ersbøll AK, Sengupta K, Pukkala E, Bolin K, Aas E, Emneus M, Ramey DR, Brady JE, Mines D, Aasbjerg K, Vestergaard C, Gislason G, Born AP, Kjærulff TM. Desloratadine exposure and incidence of seizure: A Nordic post-authorization safety study using a new-user cohort study design, 2001-2015. Drug Saf. 2021;44(11):1231–1242.
Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, Beran D. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64(12):2741–2750.
Jakobsen E, Olsen KE, Bliddal M, Hornbak M, Persson GF, Green A. Forecasting lung cancer incidence, mortality, and prevalence to year 2030. BMC Cancer. 2021;21(1):985.
Ankarfeldt MZ, Petersen J, Andersen JT, Fernandens MFS, Li H, Motsko SP, Fast T, Jimenez-Solem E. Duloxetine exposure during pregnancy, and the risk of spontaneous and elective abortion: A Danish nationwide observational study. Drugs –Real World Outcomes. 2021;8(3):289–299
Andersen V, Pedersen AK, Möller S, Green A. Chronic Inflammatory Diseases – Diabetes Mellitus, Rheumatoid Arthritis, Coeliac Disease, Crohn’s Disease, and Ulcerative Colitis Among the Offspring of Affected Parents: A Danish Population-Based Registry Study. Clin Epidemiol 13: 13-20, 2021 (E-pub: 7 January 2021).
Kolehmainen S, Ylisaukko-oja T, Jokelainen J, Koivusalo M, Jokiranta TS, Sipponen T. Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting. Scand J Gastroenterol. 2021;56(8):906–913.
Mattson TO, Pottegård A, Jørgensen TL, Green A, Bliddal M. End-of-life anticancer treatment – a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies. Acta Oncol. 2021; 60(8): 961–967.
Halminen O, Vesikansa A, Mehtälä J, Hörhammer I, Mikkola T, Virta LJ, Ylisaukko-oja T, Linna M. Early start of anti-dementia medication delays transition to 24-Hour care in Alzheimer’s disease patients: A Finnish nationwide cohort study. J Alzheimers Dis. 2021;81(3):1103–1115.
Gerhardsson P, Schwandt A, Witsch M, Kordonouri O, Svensson J, Forsander G, Battelino T, Veeze H, Danne T. The SWEET Project 10-Year Benchmarking in 19 Countries Worldwide Is Associated with Improved HbA1c and Increased Use of Diabetes Technology in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021;23(7):491–499
Ventola H, Vesikansa A, Jokelainen J, Siitonen T, Ettala P, Laine O, Lehtinen E, Lepäntalo A, Patronen M, Partanen A, Linna M, Ylisaukko-oja T, Lassila R. Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland. Haemophilia. 2021;27(1):e30-e39.
Torvinen S., Vihervaara V., Miettinen T., Jokelainen J., Bauer M., Marttila A., Tamminen K., Salonen J. Multiple Myeloma Treatments, Outcomes, and Costs of Health Care Resource Utilisation During 2009-2016, Based on Multiple Data Sources from a Hospital District in Finland, International Journal of Clinical and Experimental Medical Sciences 2021; 7(1): 21-30.
Vesikansa A, Aspholm S, Kiviniemi-Pekola, M. Lihavuus kroonisena sairautena: työterveyden näkökulma. Työterveyslääkäri 2021;39(2):50-52.
2020:
Ventola H, Vesikansa A, Siitonen T, Jokelainen J, Ettala P, Laine O, Lehtinen E, Lepäntalo A, Partanen A, Ylisaukko-oja T, Lassila R. Hemofilian hoito ja kustannukset Suomessa. Suomen Lääkärilehti 2020;75(1–2):45–49.
Article: https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/hemofilian-hoito-ja-kustannukset-suomessa/
In Press: https://www.medengine.fi/in-press/clinical-practice-and-treatment-costs-of-haemophilia-in-finland/
Georgescu V, Green A, Jensen PB, Möller S, Renard E, Mercier G. Primary care visits can reduce the risk of potentially avoidable hospitalizations among persons with diabetes in France. Eur J Public Health. 2020;30(6):1056-1061.
Article: https://academic.oup.com/eurpub/article/30/6/1056/5897695#.YUrNATlF-BE.link
PubMed: https://pubmed.ncbi.nlm.nih.gov/32851398/
Kristensen MS, Green A, Nybo M, Hede SM, Mikkelsen KH, Gislason G, Larsen ML, Ersbøll AK. Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study. BMC Cardiovasc Disord. 2020;20(1):336.
Article: https://doi.org/10.1186/s12872-020-01616-9
PubMed: https://pubmed.ncbi.nlm.nih.gov/32660429/
Vesikansa A, Jokelainen J, Mehtälä J, Mutanen K, Lundqvist A, Laatikainen T, Ylisaukko-oja T, Saukkonen T, Pietiläinen KH. Lihavuuden yhteys elämänlaatuun ja työkykyyn suomalaisessa aikuisväestössä. Suomen Lääkärilehti 2020;45:2377–2384.
Article:https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/lihavuuden-yhteys-elamanlaatuun-ja-tyokykyyn-suomalaisessa-aikuisvaestossa/
In Press: https://www.medengine.fi/in-press/in-press-obesity-is-associated-with-poor-quality-of-life-and-working-ability-among-finnish-adults/
Poulsen CD, Green A, Grauslund J, Peto T: Long-term outcome of patients operated with pars plana vitrectomy for primary rhegmatogeneous retinal detachment. Ophthalmic Res. 2020;63:25-33.
Article: https://doi.org/10.1159/000499130
PubMed: https://pubmed.ncbi.nlm.nih.gov/31013505/
Andersen V, Möller S, Jensen PB, Møller FT, Green A. Caesarean delivery and risk of chronic inflammatory disease (inflammatory bowel disease, rheumatoid arthritis, coeliac disease, and diabetes mellitus): A population based registry study of 2,699,479 births in Denmark during 1973-2016. Clin Epidemiol. 2020;12: 287-293.
Article: https://doi.org/10.2147/CLEP.S229056
PubMed: https://pubmed.ncbi.nlm.nih.gov/32210632/
Andersen IB, Brasen CL, Nasimi H, Stougård M, Bliddal M, Green A, Schmedes A, Brandslund I, Madsen JS. Serum vitamin K1 associated to microangiopathy and/or macroangiopathy in individuals with and without diabetes. BMJ Open Diab Res Care. 2020;8(1):e000961.
Article: http://dx.doi.org/10.1136/bmjdrc-2019-000961
PubMed: https://pubmed.ncbi.nlm.nih.gov/32213490/
Kjaerulff TM, Ersbøll AK, Pukkala E, Bolin K, Green A, Emneus M, Brasso K, Iversen P, Thygesen LC. Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual-level data from Denmark, Finland, and Sweden. Pharmacoepidemiol Drug Saf. 2020;29(4):453-460.
Article: https://doi.org/10.1002/pds.4947
PubMed: https://pubmed.ncbi.nlm.nih.gov/32048414/
2019:
Linna M, Vuoti S, Silander K, Hörhammer I, Halminen O, Mikkola T, Koivuranta-Vaara P, Virta LJ, Koivusalo M, Ylisaukko-oja T. Impact of anti-dementia medication on the risk of death and causes of death in Alzheimer’s disease. J Alzheimers Dis. 2019;71(4):1297-1308.
Article: https://content.iospress.com/articles/journal-of-alzheimers-disease/jad190288
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/?term=Early+start+of+anti-dementia+medication
In Press: https://www.medengine.fi/in-press/early-start-of-anti-dementia-medication-reduces-the-risk-of-death-in-alzheimers-disease/
Ylisaukko-oja T, Torvinen S, Ventola H, Schmidt S, Herrala S, Kononoff J, Voutilainen M. Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab. Scand J Gastroenterol. 2019;54(6):726-732.
Article: https://doi.org/10.1080/00365521.2019.1627579
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31203693
In Press: https://www.medengine.fi/in-press/ibd-constitutes-a-significant-economic-burden-to-finnish-healthcare-system/
Kristensen MS, Kjærulff TM, Ersbøll AK, Green A, Hallas J, Thygesen LC. The Influence of Antidepressants on the Disease Course Among Patients With Crohn’s Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study. Inflamm. Bowel Dis. 2019;25(5):886-893.
Article: https://doi.org/10.1093/ibd/izy367
PubMed: https://pubmed.ncbi.nlm.nih.gov/30551218/
Kjaerulff TM, Ersboll AK, Green A, Emneus M, Brasso K, Iversen P, Pukkala E, Bolin K, Thygesen LC. Finasteride use and risk of male breast cancer: A case-control study using individual-level registry data from Denmark, Finland, and Sweden. Cancer Epidemiol Biomarkers Prev. 2019;28(5):980-986.
Article: https://cebp.aacrjournals.org/content/28/5/980
PubMed: https://pubmed.ncbi.nlm.nih.gov/30842126/
Sengupta K, Thygesen LC, Kristiansen IS, Bolin K, Pukkala E, Emneus M, Christensen LB, Ersbøll AK. Utilization of etoricoxib in dental patients in the Nordic countries: a population-based register study. Acta Odontol Scand. 2019;77(8):584-591.
Article: https://doi.org/10.1080/00016357.2019.1622037
PubMed: https://pubmed.ncbi.nlm.nih.gov/31190596/
Brønserud MM, Iachina M, Green A, Groenvold M, Jakobsen E. Patient reported outcome data as performance indicators in surgically treated lung cancer patients. Lung Cancer 2019;130:143-148.
Article: https://doi.org/10.1016/j.lungcan.2019.02.010
PubMed: https://pubmed.ncbi.nlm.nih.gov/30885335/
Poulsen CD, Petersen MP, Green A, Peto T, Grauslund J. Fundus autofluorescence and spectral domain optical coherence tomography as predictors for long-term functional outcome in rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmology. 2019;257(4):715-23.
Article: https://doi.org/10.1007/s00417-018-04222-w
PubMed: https://pubmed.ncbi.nlm.nih.gov/30617581/
Brink M, Green A, Bojesen AB, Lamberti JS, Conwell Y, Andersen K. Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide Danish register study. Schizophr Res. 2019;206:347-354.
Article: https://doi.org/10.1016/j.schres.2018.10.020
PubMed: https://pubmed.ncbi.nlm.nih.gov/30527270/
Bank S, Julsgaard M, Abed OK, Burisch J, Broder Brodersen J, Pedersen NK, Gouliaev A, Ajan R, Nytoft Rasmussen D, Honore Grauslund C, Roug S, Galsgaard J, Sprogøe Høyer Finsen D, Lindby K, Danish IBD Genetics Working Group; Sørensen J, Larsen L, Rohr Andersen M, Brandslund I, Thomassen M, Green A, Bo Bojesen A, Bek Sørensen S, Vogel U, Andersen V. Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49(7):890-903.
Article: https://doi.org/10.1111/apt.15187
PubMed: https://pubmed.ncbi.nlm.nih.gov/30811631/
Patterson CC, Harjutsalo V, Rosenbauer J, Neu A, Cinek O, Skrivarhaug T, Rami-Merhar B, Soltesz G, Svensson J, Parslow RC, Castell C, Schoenle EJ, Bingley PJ, Dahlquist G, Jarosz-Chobot PK, Marčiulionytė D, Roche EF, Rothe U, Bratina N, Ionescu-Tirgoviste C, Weets I, Kocova M, Cherubini V, Rojnic Putarek N, deBeaufort CE, Samardzic M, Green A. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: A multicentre prospective registration study. Diabetologia. 2019;62(3):408-417.
Article: https://doi.org/10.1007/s00125-018-4763-3
PubMed: https://pubmed.ncbi.nlm.nih.gov/30483858/
Komkova A, Brandt CJ, Hansen Pedersen D, Emneus M, Sortso C. Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study. JMIR Diabetes. 2019;4(1):e12140.
Article: https://doi.org/10.2196/12140
PubMed: https://pubmed.ncbi.nlm.nih.gov/30860486/
Ylisaukko-oja T, Torvinen S, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, Salminen K, Moilanen V, Hakala K, Kellokumpu M, Toljamo K, Rautiainen H, Kuisma J, Peräaho M, Molander P, Silvennoinen J, Liukkonen V, Henricson H, Tillonen J, Esterinen M, Nielsen C, Hirsi E, Lääne M, Suhonen UM, Vihriälä I, Mäkelä P, Puhto M, Punkkinen J, Sulonen H, Herrala S, Jokelainen J, Tamminen K, Sipponen T. Characterization of inflammatory bowel disease management by vedolizumab and concomitant treatments in real-life clinical practice. Biologicals. 2019;58:50-56.
Article: https://www.sciencedirect.com/science/article/pii/S1045105618303300?via%3Dihub
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30755369
In Press: https://www.medengine.fi/en/in-press-vedolizumab-may-have-a-real-life-corticosteroid-sparing-effect/
Brønserud MM, Iachina M, Green A, Groenvold M, Dørflinger L, Jakobsen E. Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study. Lung Cancer 2019;128:67-73.
Article: https://doi.org/10.1016/j.lungcan.2018.12.014
PubMed: https://pubmed.ncbi.nlm.nih.gov/30642456/
Mølstrøm J, Grønne M, Green A, Bakholdt V, Sørensen JA. Topographical distribution of sentinel nodes and metastases from T1-T2 oral squamous cell carcinomas. Eur J Cancer 2019;107:86-92.
Article: https://doi.org/10.1016/j.ejca.2018.10.021
PubMed: https://pubmed.ncbi.nlm.nih.gov/30553161/
2018:
Aagaard KS, Kjeldsen AD, Tørring PM, Green A. Comorbidity among HHT patients and their controls in a 20 years follow-up period. Orphanet J Rare Dis. 2018;13(1):223.
Article: https://doi.org/10.1186/s13023-018-0962-8
Pubmed: https://pubmed.ncbi.nlm.nih.gov/30547819/
Ylisaukko-oja T, Jokelainen J, Sipponen T. Vedolitsumabin vaikuttavuus suomalaisten IBD-potilaiden hoidossa. Best Practice Gastroenterologia 10/2018.
Article: https://bestprac.fi/2018/10/04/vedolitsumabin-vaikuttavuus-suomalaisten-ibd-potilaiden-hoidossa/
Vlad A, Serban V, Green A, Möller S, Vlad M, Timar B, Sima A, ONROCAD Study Group. Time trends, regional variability and seasonality regarding the incidence of type 1 diabetes mellitus in romanian children aged 0-14 years, between 1996 and 2015. J Clin Res Pediatr Endocrinol. 2018;10(2):92-99.
Article: http://doi.org/10.4274/jcrpe.5456
Pubmed: https://pubmed.ncbi.nlm.nih.gov/29082895/
Sortso C, Komkova A, Sandbaek A, Griffin SJ, Emneus M, Lauritzen T, Simmons RK. Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2018;61(6):1306-1314.
Article: https://doi.org/10.1007/s00125-018-4594-2
Pubmed: https://pubmed.ncbi.nlm.nih.gov/29549417/
Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB. Social inequality in diabetes patients’ morbidity patterns from diagnosis to death – A Danish register-based investigation. Scand J Public Health. 2018;46(1):92-101.
Article: https://doi.org/10.1177%2F1403494817713648
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28671031/
Ylisaukko-oja T, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, Salminen K, Moilanen V, Hakala K, Kellokumpu M, Toljamo K, Rautiainen H, Kuisma J, Peräaho M, Molander P, Silvennoinen J, Liukkonen V, Henricson H, Tillonen J, Esterinen M, Nielsen C, Hirsi E, Lääne M, Suhonen UM, Vihriälä I, Mäkelä P, Puhto M, Punkkinen J, Sulonen H, Herrala S, Jokelainen J, Tamminen K, Sipponen T. High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO). Scand J Gastroenterol. 2018;53(2):158-167.
Article: https://www.tandfonline.com/doi/full/10.1080/00365521.2017.1416160
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/29258369
In Press: https://www.medengine.fi/en/press-real-world-treatment-outcomes-vedolizumab-among-finnish-ibd-patients-finvedo/
Meijer M, Thygesen LC, Green A, Emneus M, Brasso K, Iversen P, Pukkala E, Bolin K, Stavem K, Ersbøll AK. Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries. Cancer Med. 2018;7(1):254-260.
Article: https://doi.org/10.1002/cam4.1273
Pubmed: https://pubmed.ncbi.nlm.nih.gov/29239131/
2017:
Grönholm A, Litkey D, Jokelainen J, Keto J, Pöyry M, Linden K, Heikkinen AM. Finnish dentists find smoking cessation important but seldom offer practical support for their patients. Community Dent Health. 2017;34(4):241-247.
Article: https://www.cdhjournal.org/issues/34-4-december-2017/854-finnish-dentists-find-smoking-cessation-important-but-seldom-offer-practical-support-for-their-patients
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/29112340
In Press: https://www.medengine.fi/in-press/in-press-finnish-dentists-find-smoking-cessation-important-but-seldom-provide-concrete-withdrawal-guidance/
Grönholm A, Karhunen-Enckell U, Liira H. Tupakasta vieroitus ennen leikkausta. Suomen Lääkärilehti 2017;72:286–289.
Article: https://www.laakarilehti.fi/tieteessa/terveydenhuoltoartikkelit/tupakasta-vieroitus-ennen-leikkausta/
In Press: http://medengine.fi/in-press-quitting-smoking-reduces-operation-risks/#.WWXHOFIglp8
Sortso C, Lauridsen J, Emneus M, Green A, Jensen PB. Socioeconomic inequality of diabetes patients’ health care utilization in Denmark. Health Econ Rev. 2017;7(1):21.
Article: https://doi.org/10.1186/s13561-017-0155-5
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28550486/
Duvnjak S, Ravn P, Green A, Andersen PE. Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study. Acta Radiol. 2017;58(8):952-958.
Article: https://doi.org/10.1177%2F0284185116679458
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27872351/
Duvnjak S, Ravn P, Green A, Andersen PE. Assessment of uterine fibroid infarction after embolization with tris-acryl gelatin microspheres. Cogent Medicine. 2017;4(1):1360543.
Article: https://doi.org/10.1080/2331205X.2017.1360543
Pubmed:
Duvnjak S, Ravn P, Green A, Andersen PE. Magnetic resonance signal intensity ratio measurement before uterine artery embolization: ability to predict fibroid size reduction. Cardiovasc Intervent Radiol. 2017;40(12):1839-1844.
Article: https://doi.org/10.1007/s00270-017-1721-2
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28597064/
Bolin K, Berggren F, Berling P, Morberg S, Gauffin H, Landtblom A-M. Patterns of antiepileptic drug prescription in Sweden: A register-based approach. Acta Neurol Scand. 2017;136(5):521-527.
Article: https://doi.org/10.1111/ane.12776
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28585316/
Brink M, Green A, Bojesen AB, Lamberti JS, Conwell Y, Andersen K. Physical health, medication, and healthcare utilization among 70-year-old people with schizophrenia: A nationwide Danish register study. Am J Geriatr Psychiatry. 2017;25(5):500-509.
Article: https://doi.org/10.1016/j.jagp.2016.12.015
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28215901/
Keto J, Ventola H, Jokelainen J, Timonen M, Linden K, Ylisaukko-oja T, Keinänen-Kiukaanniemi S, Auvinen J. Primary health care utilisation and its costs among middle-aged smokers. Eur J Health Econ. 2017;18(3):351-360.
Article: http://link.springer.com/article/10.1007%2Fs10198-016-0793-2
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/27008029
In Press: http://medengine.fi/primary-health-care-utilization-and-costs-are-significantly-increased-among-middle-aged-smokers/#.WGS0uXcgnUo
Mygind L, Kryger T, Sidenius G, Schipperijn J, Bentsen P. A school excursion to a museum can promote physical activity in children by integrating movement into curricular activities. Eur Phys Educ Rev. 2017;25(1):35-47.
Article: https://doi.org/10.1177%2F1356336X17700660
Pubmed:
Iachina M, Jakobsen E, Fallesen AK, Green A. Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study. BMC Health Serv Res. 2017;17(1):267.
Article: https://doi.org/10.1186/s12913-017-2230-3
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28403839/
Iachina M, Bronserud MM, Jakobsen E, Trosko O, Green A. History of Depression in Lung Cancer Patients: Impact of Delay. Clin Oncol (R Coll Radiol). 2017;29(9):585-592.
Article: https://doi.org/10.1016/j.clon.2017.03.014
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28416086/
Hollins O, Lee P, Sims E, Bertham O, Symington H, Bell N, Pfaltzgraff L, Sjögren P. Towards a circular economy – Waste management in the EU. European Parliamentary Research Service 2017.
Article: EPRS_STU(2017)581913_EN.pdf (europa.eu)
Pubmed:
Blindbaek SL, Schlosser A, Green A, Holmskov U, Sorensen GL, Grauslund J. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus. Acta Diabetol. 2017;54(4):367-372.
Article: https://doi.org/10.1007/s00592-016-0953-y
Pubmed: https://pubmed.ncbi.nlm.nih.gov/28039584/
ApEHR, the Danish Multidisciplinary Cancer Groups (DMCG.dk) & the Danish Clinical Registries (RKKP, Regionernes Kliniske Kvalitetsudviklingsprogram). Benchmarking II Report. 2017.
LIVA Healthcare 2017 Cost-Effectiveness Analysis. ApEHR; 2017.
Article: https://livahealthcare.com/wp-content/uploads/2018/11/Report_Apehr_2017.pdf
2016:
Engberg H, Wehberg S, Bistrup C, Heaf J, Sorensen SS, Thiesson HC, Hansen JM, Svensson M, Green A; Marckmann P. Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids. Nephrol Dial Transplant. 2016;31(12):2149-156.
Article: https://doi.org/10.1093/ndt/gfw304
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27587604/
Kjeldsen A, Aagaard KS, Tørring PM, Möller S, Green A. 20-year follow-up study of Danish HHT patients—survival and causes of death. Orphanet J Rare Dis. 2016;11(1):157.
Article: https://doi.org/10.1186/s13023-016-0533-9
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27876060/
Poulsen CD, Peto T, Grauslund J, Green A. Epidemiologic characteristics of retinal detachment surgery at a specialized unit in Denmark. Acta Ophthalmol. 2016;94(6):548-555.
Article: https://doi.org/10.1111/aos.13113
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27238952/
Keto J, Ventola H, Jokelainen J, Linden K, Keinänen-Kiukaanniemi S, Timonen M, Ylisaukko-oja T, Auvinen J. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016;3(2):e000358.
Article: http://openheart.bmj.com/content/3/2/e000358
Pubmed : https://www.ncbi.nlm.nih.gov/pubmed/27493759
In Press: http://medengine.fi/in-press-smoking-is-a-major-independent-risk-factor-for-cardiovascular-disease-in-middle-aged-population/#.WWXHpFIglp8
Joergensen TM, Christensen K, Lindholt JS, Larsen LA, Green A, Houlind K. Editor’s choice – high heritability of liability to abdominal aortic aneurysms: A population based twin study. Eur J Vasc Endovasc Surg. 2016;52(1):41-46.
Article: https://doi.org/10.1016/j.ejvs.2016.03.012
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27107486/
Sortso C, Green A, Jensen PB, Emneus M. Societal costs of diabetes mellitus in Denmark. Diabet Med. 2016;33(7):877-885.
Article: https://doi.org/10.1111/dme.12965
Pubmed: https://pubmed.ncbi.nlm.nih.gov/26414087/
Kjaerulff TM, Ersboll AK, Green A, Emneus M, Pukkala E, Bolin K, Stavem K, Iversen P, Brasso K, Hallas J, Thygesen LC. Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study. Scand J Urol. 2016;50(3):220-227.
Article: https://doi.org/10.3109/21681805.2015.1136676
Pubmed: https://pubmed.ncbi.nlm.nih.gov/26901820/
Jakobsen E, Rasmussen TR, Green A. Mortality and survival of lung cancer in Denmark: Results from the Danish Lung Cancer Group 2000-2012. Acta Oncol. 2016;55(Suppl 2):2-9.
Article: https://doi.org/10.3109/0284186X.2016.1150608
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27056247/
Iversen LH, Green A, Ingeholm P, Osterlind K, Gogenur I. Improved survival of colorectal cancer in Denmark during 2001-2012 – The efforts of several national initiatives. Acta Oncol. 2016;55 (Suppl 2):10-23.
Article: https://doi.org/10.3109/0284186X.2015.1131331
Pubmed: https://pubmed.ncbi.nlm.nih.gov/26859340/
Green A, Pottegård A, Broe A, Diness TG, Emneus M, Hasvold P, Gislason GH. Initiation and persistence with dual antiplatelet therapy after acute myocardial infarction: a Danish nationwide population-based cohort study. BMJ Open. 2016;6(5):e010880.
Article: http://dx.doi.org/10.1136/bmjopen-2015-010880
Pubmed: https://pubmed.ncbi.nlm.nih.gov/27173812/
Sandler N, Holländer J, Långström D, Santtila P, Saukkonen A, Torvinen S. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler). BMJ Open Respir Res. 2016;3(1):e000119.
Article: http://bmjopenrespres.bmj.com/content/3/1/e000119
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/27026804
Sortsø C, Lauridsen J, Emneus M, Green A, Jensen PB: “Decomposing Inequality in Diabetes Patients’ Morbidity Patterns, Survival and Health Care Usage in Denmark.” COHERE – Centre of Health Economics Research, Discussion Papers. Department of Business and Economics, Faculty of Business and Social Sciences, University of Southern Denmark, 2016.
Article: http://www.sdu.dk/-/media/files/om_sdu/centre/cohere/working+papers/2016/wp_2016_2.pdf?la=da
Green A, Hauge J, Iachina M, Jakobsen E. The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry. Eur J Cardiothorac Surg. 2016;49(2):589-594.
Article: https://doi.org/10.1093/ejcts/ezv107
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25825264/
Duvnjak S, Ravn P, Green A, Andersen PE. Clinical Long-Term Outcome and Reinterventional Rate After Uterine Fibroid Embolization with Nonspherical Versus Spherical Polyvinyl Alcohol Particles. Cardiovasc Intervent Radiol. 2016;39(2):204-209.
Article: https://doi.org/10.1007/s00270-015-1157-5
Pubmed: https://pubmed.ncbi.nlm.nih.gov/26122738/
2015:
Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Kržišnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M, de Beaufort CE, Green A, Soltész G, Dahlquist GG. Seasonal variation in month of diagnosis in children with type 1 diabetes registered in 23 European centers during 1989-2008: little short-term influence of sunshine hours or average temperature. Pediatr Diabetes. 2015;16(8):573-80.
Article: https://doi.org/10.1111/pedi.12227
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25316271/
Keto J, Jokelainen J, Timonen M, Linden K, Ylisaukko-oja T. Physicians discuss the risks of smoking with their patients, but seldom offer practical cessation support. Subst Abuse Treat Prev Policy. 2015;10:43.
Article: https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-015-0039-9
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/26525302
Sortsø C, Emneus M, Green A, Jensen P, Eriksson T. Societal Costs of Diabetes Mellitus 2025 and 2040—Forecasts Based on Real World Cost Evidence and Observed Epidemiological Trends in Denmark. Modern Economy. 2015;6(10):1150-66.
Article: http://dx.doi.org/10.4236/me.2015.610109
Green A, Sortso C, Jensen PB, Emneus M. Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013. Clin Epidemiol. 2015;7:421-30.
Article: https://doi.org/10.2147/CLEP.S88577
Pubmed: https://pubmed.ncbi.nlm.nih.gov/26604822/
Iachina M, Jakobsen E, Møller H, Lüchtenborg M, Mellemgaard A, Krasnik M, Green A. The Effect of Different Comorbidities on Survival of Non-small Cells Lung Cancer Patients. Lung. 2015; 193(2):291-7.
Article: https://doi.org/10.1007/s00408-014-9675-5
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25516286/
Thomsen L, Lindholt J, Roeder O, Green A, Mikkelsen RT. Excess mortality during the first year after arterial trauma. Dan Med J. 2015;62(3): A5013.
Article: Ugeskriftet.dk
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25748860/
Bank S, Andersen PS, Burisch J, Pedersen N, Roug S, Galsgaard J, Turino SY, Brodersen JB, Rashid S, Avlund S, Olesen TB, Green A, Hoffmann HJ, Thomsen MK, Østergaard Thomsen V, Andersen Nexø B, Vogel U, Andersen V. Effectiveness of anti-tumour necrosis factor-alpha therapy in Danish patients with inflammatory bowel diseases. Dan Med J. 2015;62(3):A4994.
Article: Ugeskriftet.dk
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25748864/
Keto J, Rautio N, Ylisaukko-oja T, Linden K, Koponen H. Mielenterveyden häiriöistä kärsivien tupakasta vieroitus. Duodecim 2015;131:855–861.
Article: https://www.duodecimlehti.fi/lehti/2015/9/duo12236
Mellemgaard A, Luchtenborg M, Iachina M, Jakobsen E, Green A, Krasnik M, Møller H. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol. 2015;10(2):272-9.
Article: https://doi.org/10.1097/JTO.0000000000000416
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25371078/
Bolin K, Berggren F, Landtblom A-M. Prevalence and cost of epilepsy in Sweden – a register-based approach. Acta Neurol Scand. 2015;131(1):37-44.
Article: https://doi.org/10.1111/ane.12297
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25195857/
Keto J, Jokelainen J, Linden K, Ylisaukko-oja T, Timonen M. Yleislääketieteen erikoislääkärien kokemat esteet tupakasta vieroituksessa. Yleislääkäri 2015;30:23-36.
Ventola H, Keto J, Jokelainen J, Linden K, Ylisaukko-oja T. Kuinka suomalaiset psykiatrit vieroittavat tupakasta. Erikoislääkäri 2015;25:550-560.
2014:
Bolin K, Berggren F, Landtblom A-M. Regional variation in prevalence and healthcare utilization due to epilepsy in Sweden. Acta Neurol Scand. 2014;130(6):354-359.
Article: https://doi.org/10.1111/ane.12274
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25040145/
Joergensen TMM, Houlind K, Green A, Lindholt JS. Abdominal aortic diameter is increased in males with a family history of abdominal aortic aneurysms: results from the Danish VIVA-trial. Eur J Vasc Endovasc Surg. 2014;48(6):669-675.
Article: https://doi.org/10.1016/j.ejvs.2014c.09.005
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25443525/
Green A, Sortsø C, Jensen PB, Emneus M. Validation of the Danish National Diabetes Register. Clin Epidemiol. 2014;7:5-15.
Article: https://doi.org/10.2147/CLEP.S72768
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25565889/
Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi AY, Ray S, Basta N, Kent C, Pedersen TR. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial. Am J Cardiol. 2014;114(10):1518-1522.
Article: https://doi.org/10.1016/j.amjcard.2014.08.016
Pubmed: https://pubmed.ncbi.nlm.nih.gov/25267716/
Nielsen AA, Petersen PH, Green A, Christensen C, Christensen H, Brandslund I. Changing from glucose to HbA1c for diabetes diagnosis: predictive values of one test and importance of analytical bias and imprecision. Clin Chem Lab Med. 2014;52(7):1069-1077.
Article: https://doi.org/10.1515/cclm-2013-0337
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24659606/
Kujanpää T, Ylisaukko-oja T, Jokelainen J, Linna M, Timonen M. Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland. Nord J Psychiatry. 2014;68(5):306-310.
Article: http://www.tandfonline.com/doi/full/10.3109/08039488.2013.817605
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/23931684
Kujanpää T, Ylisaukko-oja T, Jokelainen J, Hirsikangas S, Kanste O, Kyngäs H, Timonen M. Prevalence of anxiety disorders among Finnish primary care high utilizers and validation of Finnish translation of GAD-7 and GAD-2 screening tools. Scand J Prim Health Care. 2014; 32(2):78-83.
Article: http://www.tandfonline.com/doi/full/10.3109/02813432.2014.920597
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/24920316
Techau M, Lunde A, Pedersen CG, Green A, Johannessen H, Nissen N. Non-participants and reasons for non-participation in a pragmatic trial of energy healing as cancer rehabilitation. Eur J Integr Med. 2014;6(3):268-276.
Article: https://doi.org/10.1016/j.eujim.2014.03.003
Nielsen AA, Christensen H, Lund ED, Christensen C, Brandslund I, Green A. Diabetes mortality differs between registers due to various disease definitions. Dan Med J. 2014;61(5):A4840.
Article: Diabetes mortality differs between registers due to various disease definitions. – Abstract – Europe PMC
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24814742/
Iachina M, Green A, Jakobsen E. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open. 2014;4(2):e003846.
Article: https://doi.org/10.1136/bmjopen-2013-003846
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24523421/
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, Brix TH. Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. Eur J Endocrinol. 2014;170(2):341-348.
Article: https://doi.org/10.1530/EJE-1c3-0708
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24282192/
Rautio N, Jokelainen J, Ekroos H, Puhakka M, Keto J, Linden K, Ylisaukko-oja T. Erikoislääkärit tupakasta vieroituksen toteuttajina. Erikoislääkäri 2014;24:41-46.
Ylisaukko-oja T, Linden K. Tupakasta vieroituksen toteutuminen työterveyslääkärien näkökulmasta. Työterveyslääkäri 2014(2):68-70.
Ylisaukko-oja T, Keto J, Jokelainen J, Timonen M, Linden K. Tupakasta vieroitus – siirtyvätkö suositukset käytäntöön? Suomen Lääkärilehti 2014;69:328-330.
2013:
Jakobsen E, Green A, Oesterlind K, Rasmussen TR, Iachina M, Palshof T. Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry. J Thorac Oncol. 2013;8(10):1238-47.
Article: https://doi.org/10.1097/JTO.0b013e3182a4070f
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24457234/
Lindholt J, Green A, Søgaard R. Screening for abdominalt aortic aneurysms has a positive clinical effect. Ugeskr Laeger 2013;175(38):2170-4
Article: https://ugeskriftet.dk/videnskab/screening-abdominalt
Pubmed: https://pubmed.ncbi.nlm.nih.gov/24044536/
Jorgensen JS, Jorgensen TM, Green A, Sjolie AK, Grauslund J. Long-term associations between serum lipids and panretinal photocoagulation in type 1 diabetes. Curr Eye Res. 2013;38(8):889-893.
Article: https://doi.org/10.3109/02713683.2013.786094
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23806047/
Gaedt Thorlund M, Borg Madsen M, Green A, Sjolie AK, Grauslund J. Is smoking a risk factor for proliferative diabetic retinopathy in type 1 diabetes? Ophthalmologica. 2013;230(1):50-54.
Article: https://doi.org/10.1159/000350813
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23751972/
Bolin K, Wachtmeister K, Stefan F, Forsgren L. Retigabine as add-on treatment of refractory epilepsy – a cost-utility study in a Swedish setting. Acta Neurol Scand. 2013;127(6):419-26.
Article: https://doi.org/10.1111/ane.12077
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23368976/
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, Brix TH. Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One. 2013; 8(6):e66711.
Article: https://doi.org/10.1371/journal.pone.0066711
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23818961/
Brandt F, Thvilum M, Almind D, Christensen K, Green A, Hegedus L, Brix TH. Graves’ disease and toxic nodular goiter are both associated with increased mortality but differ with respect to the cause of death: a Danish population-based register study. Thyroid. 2013;23(4):408-413.
Article: https://doi.org/10.1089/thy.2012.0500
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23253072/
Laursen JV, Hoffmann SS, Green A, Nybo M, Sjolie AK, Grauslund J. Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients. Curr Eye Res. 2013;38(1):174-179.
Article: https://doi.org/10.3109/02713683.2012.713153
Pubmed: https://pubmed.ncbi.nlm.nih.gov/22906118/
Ali S, Mealing S, Hawkins N, Lescrauwaet B, Bjork S, Mantovani L, Lampertico P. The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. BMJ Open. 2013;3(1):e001309.
Article: https://dx.doi.org/10.1136%2Fbmjopen-2012-001309
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23355658/
2012:
Brandt F, Almind D, Christensen K, Green A, Brix TH, Hegedus L. Excess mortality in hyperthyroidism: the influence of preexisting comorbidity and genetic confounding: a danish nationwide register-based cohort study of twins and singletons. J Clin Endocrinol Metab. 2012; 97(11):4123-4129.
Article: https://doi.org/10.1210/jc.2012-2268
Pubmed: https://pubmed.ncbi.nlm.nih.gov/22930783/
Hansen S, Green A, Nielsen J, Haugaard M, Laursen R, Schultz H, Rasmussen B, Broholm H, Andersen P, Kosteljanetz M, styregruppen for DNOR. Danish Neuro-Oncology Registry. Ugeskr Laeger. 2012;174(42):2558.
Article: Ugeskriftet.dk
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23079461/
Jakobsen E, Green A, Østerlind K, Palshof T. Dansk Lunge Cancer Register. Dan Med J. 2012; 174(42):2539.
Pubmed: https://pubmed.ncbi.nlm.nih.gov/23079442/
Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, Bingley PJ, Schoenle E, Jarosz-Chobot P, Urbonaité B, Rothe U, Krzisnik C, Ionescu-Tirgoviste C, Weets I, Kocova M, Stipancic G, Samardzic M, de Beaufort CE, Green A, Dahlquist GG, Soltész G. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia. 2012;55(8):2142-2147.
Article: https://doi.org/10.1007/s00125-012-2571-8
Pubmed: https://pubmed.ncbi.nlm.nih.gov/22638547/
Karlberg C, Falk C, Green A, Sjolie AK, Grauslund J. Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients. Acta Diabetol. 2012; 49(4):263-268.
Article: https://doi.org/10.1007/s00592-011-0304-y
Pubmed: https://pubmed.ncbi.nlm.nih.gov/21688016/
Kaerlev L, Iachina M, Pedersen JH, Green A, Norgard BM. CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer. 2012;12:188.
Article: https://doi.org/10.1186/1471-2407-12-188
Pubmed: https://pubmed.ncbi.nlm.nih.gov/22621716/
2011:
Brandt F, Green A, Hegedus L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol. 2011;165(4):491-497.
Article: https://doi.org/10.1530/EJE-11-0299
Pubmed: https://pubmed.ncbi.nlm.nih.gov/21724839/
Green A. Danish clinical databases: an overview. Scand J Public Health. 2011;39(7 Suppl):68-71.
Article: https://doi.org/10.1177%2F1403494811402413
Pubmed: https://pubmed.ncbi.nlm.nih.gov/21775356/
Grauslund J, Green A, Sjolie AK. Cataract surgery in a population-based cohort of patients with type 1 diabetes: long-term incidence and risk factors. Acta Ophthalmol. 2011;89(1):25-9.
Article: https://doi.org/10.1111/j.1755-3768.2009.01619.x
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19764915/
2010:
Grauslund J, Nybo M, Green A, Sjolie AK. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes. Scand J Clin Lab Invest. 2010;70(6):392-398.
Article: https://doi.org/10.3109/00365513.2010.497869
Pubmed: https://pubmed.ncbi.nlm.nih.gov/20575653/
Grauslund J, Jorgensen TM, Nybo M, Green A, Rasmussen LM, Sjolie AK. Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetes. J Diabetes Complications. 2010;24(4):223-228.
Article: https://doi.org/10.1016/j.jdiacomp.2009.05.003
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19577486/
Grauslund J, Green A, Kawasaki R, Hodgson L, Sjolie AK, Wong TY. Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology. 2010;117(7): 1400-1405.
Article: https://doi.org/10.1016/j.ophtha.2009.10.047
Pubmed: https://pubmed.ncbi.nlm.nih.gov/20176399/
Bolin K, Berggren F, Forsgren L. Lacosamide as treatment of epileptic seizures – cost utility results for Sweden. Acta Neurol Scand. 2010;121(6):406-412.
Article: https://doi.org/10.1111/j.1600-0404.2010.01342.x
Pubmed: https://pubmed.ncbi.nlm.nih.gov/20199516/
Grauslund J, Rasmussen LM, Green A, Sjolie AK. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? Scand J Clin Lab Invest. 2010; 70(3):188-193.
Article: https://doi.org/10.3109/00365511003653599
Pubmed: https://pubmed.ncbi.nlm.nih.gov/20205614/
Laustrup H, Voss A, Green A, Junker P. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. Lupus. 2010;19(3):239-246.
Article: https://doi.org/10.1177%2F0961203309351033
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19946037/
2009:
Jorgensen TM, Grauslund J, Sjolie AK, Green A, Rasmussen LM, Nybo M. Major diabetes-related vascular events do not improve glycaemic control in a population-based cohort of type 1 diabetic individuals. Scand J Clin Lab Invest. 2009;69(7):748-751.
Article: https://doi.org/10.3109/00365510903108410
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19929717/
Grauslund J, Green A, Sjolie AK. Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. Ophthalmology. 2009;116(11):2170-2174.
Article: https://doi.org/10.1016/j.ophtha.2009.04.043
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19744716/
Grauslund J, Hodgson L, Kawasaki R, Green A, Sjolie AK, Wong TY. Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes. Diabetologia. 2009;52(10):2213-2217.
Article: https://doi.org/10.1007/s00125-009-1459-8
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19618163/
Van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004. Value Health. 2009;12(6):909-914.
Article: https://doi.org/10.1111/j.1524-4733.2009.00506.x
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19508664/
Grauslund J, Green A, Sjolie AK. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia. 2009;52(9):1829-1835.
Article: https://doi.org/10.1007/s00125-009-1450-4
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19593541/
Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet. 2009;373(9680):2027-33.
Article: https://doi.org/10.1016/S0140-6736(09)60568-7
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19481249/
Laustrup H, Voss A, Green A, Junker P. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study. Scand J Rheumatol. 2009;38(2):128-132.
Article: https://doi.org/10.1080/03009740802419073
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19117248/
2008:
Gopinath S, Ortqvist E, Norgren S, Green A, Sanjeevi CB. Variations in incidence of type 1 diabetes in different municipalities of Stockholm. Ann N Y Acad Sci. 200;1150:200-207.
Article: https://doi.org/10.1196/annals.1447.057
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19120295/
Kyvik K, Green A. Genetic epidemiology of Type 1 diabetes mellitus. In: Ekoé J-M, Rewers M, Williams R, Zimmet P, editors. The epidemiology of diabetes mellitus. Second ed. Chichester: John Wiley & Sons; 2008 Sep. p. 403-12.
Article: https://doi.org/10.1002/9780470779750.ch26
Stochholm K, Laursen T, Green A, Laurberg P, Andersen M, Kristensen LO, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Gravholt CH. Morbidity and GH deficiency: a nationwide study. Eur J Endocrinol. 2008;158(4):447-57.
Article: https://doi.org/10.1530/eje-07-0523
Pubmed: https://pubmed.ncbi.nlm.nih.gov/18362290/
Grauslund J, Green A, Sjolie AK. Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark. Diabetologia. 2008;51(4):583-588.
Article: https://doi.org/10.1007/s00125-008-0953-8
Pubmed: https://pubmed.ncbi.nlm.nih.gov/18297258/
Green A, Emneus M. Diabetesepidemien i Danmark: Hvad foregår der og hvor skal vi hen? Tidsskrift for Dansk Sundhedsvæsen. 2008;7:199-203.
Article: 1071198.pdf (ft.dk)
Green A. Descriptive epidemiology of type 1 diabetes in youth: incidence, mortality, prevalence, and secular trends. Endocr Res. 2008;33(1-2):1-15.
Article: https://doi.org/10.1080/07435800802079924
Pubmed: https://pubmed.ncbi.nlm.nih.gov/19156571/
Bolin K. Health among long-term survivors of breast cancer—an analysis of 5-year survivors based on the Swedish surveys of living conditions 1979–1995 and the Swedish Cancer Registry 2000. Psycho-Oncology. 2008;17(1):1-8.
Article: https://doi.org/10.1002/pon.1189
Pubmed: https://pubmed.ncbi.nlm.nih.gov/17385191/
2007:
Stochholm K, Gravholt CH, Laursen T, Laurberg P, Andersen M, Kristensen LO, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A. Mortality and GH deficiency: a nationwide study. Eur J Endocrinol. 2007;157(1):9-18.
Article: https://doi.org/10.1530/EJE-07-0013
Pubmed: https://pubmed.ncbi.nlm.nih.gov/17609396/
Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Counting drugs to understand the disease: the case of measuring the diabetes epidemic. Popul Health Metr. 2007;5:2.
Article: https://doi.org/10.1186/1478-7954-5-2
Pubmed: https://pubmed.ncbi.nlm.nih.gov/17313683/
Kristensen J, Drivsholm T, Carstensen B, Steding-Jessen M, Green A. Validering af metoder til identifikation af erkendt diabetes på basis af administrative sundhedsregistre. Dan Med J. 2007;169(18):1687-92.
Article: https://ugeskriftet.dk/videnskab/validering-af-metoder-til-identifikation-af-erkendt-diabetes-paa-basis-af-administrative
Pubmed: https://pubmed.ncbi.nlm.nih.gov/17532878/
2006:
Stochholm K, Gravholt CH, Laursen T, Jorgensen JO, Laurberg P, Andersen M, Kristensen LØ, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A. Incidence of GH deficiency – a nationwide study. Eur J Endocrinol. 2006;155(1):61-71.
Article: https://doi.org/10.1530/eje.1.02191
PubMed: https://pubmed.ncbi.nlm.nih.gov/16793951/
Green A, Rasmussen S, Emneus M. Sundhedsøkonomiske omkostninger og benefits ved behandling af diabetes mellitus i Danmark. Behandlerbladet. 2006 December:6-11
Article: Sundhedsøkonomiske omkostninger og benefits ved behandling af diabetes mellitus i Danmark – VIVE
